The Parenteral Drug Association (PDA) is an international non-profit industry trade group for pharmaceutical and biopharmaceutical manufacturers.
Founded in 1946 (77 years ago) as the Parenteral Drug Association by a small group of pharmaceutical manufacturers who recognized the need for an organization to disseminate technical information within the industry, it now has more than 11,000 members worldwide.
[1] PDA has members in 74 countries and regions: Africa Botswana, Egypt, Ghana, South Africa, Tunisia, Zimbabwe Asia Bangladesh, China, India, Pakistan Caribbean, Central, & South America Argentina, Brazil, Colombia, Costa Rica, Dominican Republic, Paraguay, Peru, Uruguay Europe Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom Middle East Cyprus, Iran, Palestine, Jordan, Saudi Arabia, Syria, Turkey, United Arab Emirates North America Canada, Mexico, Puerto Rico, United States Pacific-Rim Australia, Hong Kong, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea, Taiwan, Thailand, Vietnam